Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma

Endocrine. 2018 Jul;61(1):169-172. doi: 10.1007/s12020-017-1428-9. Epub 2017 Oct 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Cortex Neoplasms / complications*
  • Adrenocortical Carcinoma / complications*
  • Adult
  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Cushing Syndrome / drug therapy*
  • Cushing Syndrome / etiology*
  • Drug Therapy, Combination
  • Feasibility Studies
  • Humans
  • Hydrocortisone / urine
  • Male
  • Metyrapone / therapeutic use*
  • Middle Aged
  • Mitotane / therapeutic use*
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Hormonal
  • Mitotane
  • Hydrocortisone
  • Metyrapone